Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Mar 28, 2025, 4:00 PM
1.350
+0.030 (2.25%)
After-hours: Mar 28, 2025, 5:59 PM EDT

Ikena Oncology Statistics

Total Valuation

Ikena Oncology has a market cap or net worth of $63.70 million. The enterprise value is -$53.16 million.

Market Cap 63.70M
Enterprise Value -53.16M

Important Dates

The last earnings date was Thursday, March 6, 2025, before market open.

Earnings Date Mar 6, 2025
Ex-Dividend Date n/a

Share Statistics

Ikena Oncology has 48.26 million shares outstanding. The number of shares has increased by 15.63% in one year.

Current Share Class 41.89M
Shares Outstanding 48.26M
Shares Change (YoY) +15.63%
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.52%
Owned by Institutions (%) 19.62%
Float 7.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.51
P/TBV Ratio 0.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.80, with a Debt / Equity ratio of 0.06.

Current Ratio 11.80
Quick Ratio 11.54
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -33.30% and return on invested capital (ROIC) is -21.72%.

Return on Equity (ROE) -33.30%
Return on Assets (ROA) -20.44%
Return on Invested Capital (ROIC) -21.72%
Return on Capital Employed (ROCE) -41.73%
Revenue Per Employee n/a
Profits Per Employee -$4.92M
Employee Count 10
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Ikena Oncology has paid $152,000 in taxes.

Income Tax 152,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -5.04% in the last 52 weeks. The beta is 0.50, so Ikena Oncology's price volatility has been lower than the market average.

Beta (5Y) 0.50
52-Week Price Change -5.04%
50-Day Moving Average 1.41
200-Day Moving Average 1.62
Relative Strength Index (RSI) 43.56
Average Volume (20 Days) 84,921

Short Selling Information

The latest short interest is 151,688, so 0.31% of the outstanding shares have been sold short.

Short Interest 151,688
Short Previous Month 139,633
Short % of Shares Out 0.31%
Short % of Float 1.92%
Short Ratio (days to cover) 1.87

Income Statement

Revenue n/a
Gross Profit -30.88M
Operating Income -54.55M
Pretax Income -66.78M
Net Income -49.23M
EBITDA -54.06M
EBIT -54.55M
Earnings Per Share (EPS) -$1.02
Full Income Statement

Balance Sheet

The company has $124.39 million in cash and $7.52 million in debt, giving a net cash position of $116.87 million or $2.42 per share.

Cash & Cash Equivalents 124.39M
Total Debt 7.52M
Net Cash 116.87M
Net Cash Per Share $2.42
Equity (Book Value) 125.93M
Book Value Per Share 2.61
Working Capital 116.39M
Full Balance Sheet

Cash Flow

Operating Cash Flow -46.00M
Capital Expenditures n/a
Free Cash Flow -46.00M
FCF Per Share -$0.95
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Ikena Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.63%
Shareholder Yield n/a
Earnings Yield -77.29%
FCF Yield -72.22%

Analyst Forecast

The average price target for Ikena Oncology is $3.00, which is 127.27% higher than the current price. The consensus rating is "Buy".

Price Target $3.00
Price Target Difference 127.27%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1